Patent Yard Sign in
Expired Canadian patentCanada

Processes and intermediates in the synthesis of 5-(3-exo-bicyclo2.2.1hept-2-yloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidin-2(1h)-one

CA 2196309 C · Owner: Murtiashaw, Charles W. · Inventors: Lacour, Thomas G.; Murtiashaw, Charles W.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed are novel processes for preparing the pharmaceutically active compound 5-(3-(2S)-exobicyclo 2.2.1 kept-2-yloxy-4-methoxyphenyl)-3 4, 5, 6-, tetrahydropyrimidin-2(1H)-one of the formula: (see formula I), and its corresponding 2R enantiomer and for preparing certain intermediates used in the synthesis of these compounds. Also disclosed are novel intermediates used in the synthesis of such pharmaceutically active compounds and other novel compounds that are related to such intermediates.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 4, 1995 and granted October 16, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 4, 2015.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 4, 2017.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 4, 1995
GrantedOctober 16, 2001
Term endedMay 4, 2015
Patent numberCA 2196309 C
Classification (IPC)C07D239/10 +2 more

Timeline

Timeline From CIPO dates

1996199820002002200420062008201020122014Application filedMay 4, 1995Patent grantedOct 16, 2001Term endedMay 4, 2015

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.